-
Racial and Geographic Disparities in Parkinson’s Disease Patients with Gastrostomy Feeding Tube Placement
-
Randomized, placebo-controlled study investigating the safety, pharmacokinetics and efficacy of inhaled apomorphine in Parkinson’s disease patients
-
Rapid on-time onset and sustained improvements in motor states throughout the day following treatment with levodopa/carbidopa intestinal gel (LCIG) vs immediate-release levodopa/carbidopa oral capsules (LCIR)
-
Rare variants of the LRRK2 gene in the haplotype as one of the potential risk factors for endemic parkinsonism in a small isolated region in the Czech Republic
-
Rate of Neuromuscular Excitation during Cycling Related to Mobility in Parkinson’s Disease
-
Rates of Pharmacological Treatment of Neuropsychiatric Symptoms in Early Parkinson’s Disease
-
RBD and autonomic dysfunction in newly diagnosed Parkinson’s disease patients
-
Real Time Quality Control for Subjective Endpoints in Clinical Trials
-
Real World Clinical Outcomes Using a Novel Directional Lead from a Multicenter Registry of Deep Brain Stimulation for Parkinson’s Disease
-
Real-World Data on the Use of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson’s Disease who are Treated with Deep Brain Stimulation: The PD-DUAL Study
-
Real-World Deutetrabenazine Dosing Patterns in Patients With Huntington’s Disease or Tardive Dyskinesia
-
Real-World Evaluation of Patient Characteristics and Disease Management in Long-Term Valbenazine Treatment in Adults with Tardive Dyskinesia
-
Real-World Evidence for a Smartwatch-based Parkinson’s Motor Assessment App in Patients Undergoing Therapy Changes
-
Real-world evidence for symptomatic relief in essential tremor using transcutaneous afferent patterned stimulation therapy
-
Real-world Evidence of Directional DBS Programming in Parkinson’s disease and Essential Tremor: The Cleveland Clinic Experience
-
Real-World Healthcare Resource Utilization in Patients with Parkinson’s Disease and Motor Fluctuations
-
Real-World Use and Impact of VMAT2 Inhibitors in Patients with Tardive Dyskinesia
-
Recent Clinical variation of Segawa Disease in Japan
-
Recent Trends in Complications after Deep Brain Stimulation Implantation: Insights from Big Data Analysis
-
Recessive CWF19L1 mutations in a family with dystonia-ataxia syndrome
-
Reclassification of variant c.5825C>T and clinical evidence of variant c.3955_3958dup in a Peruvian family with ATM syndrome
-
Red blood cells alpha-synuclein heteroaggregates in the differential diagnosis of Lewy body dementias, Alzheimer’s disease and healthy controls
-
Reduced Striatal VMAT2 in REM Sleep Behavior Disorder: A Gateway to Preclinical Parkinson’s Disease
-
Reduction of OFF time with apomorphine infusion during hours of pump use: Analysis from a Phase III, open-label study
-
Refining Knowledge on the Treatment of Pisa Syndrome with Botulinum Toxin
-
Refractory cervical dystonia: is the infiltration of the obliquus capitis inferior muscle a game changer?
-
Refractory tremor: is perampanel a potentially useful therapy?
-
Regional cortical thickness alterations in PD patients with cognitive impairment
-
Regional free-water differentially associated with glial activation, neuroinflammation, and neurodegeneration in de novo Parkinson’s disease
-
Regional, Not Global, Functional Connectivity Contributes to Isolated Focal Dystonia
-
Relationship Between a-syn RT-QuIC and a-syn Neuropathologic Burden in Dementia with Lewy Bodies
-
Relationship between REM sleep without atonia and sleep architecture in multiple system atrophy
-
Relationship between tumor and very slow Parkinson`s disease progression
-
Reliability and Stability of Programming Directional Deep Brain Stimulation
-
Remote and frequent assessment of Huntington’s disease in clinical trials: Strategies for assessing and accounting for the practice effect
-
Remote monitoring of physical activity and falls in patients with Huntington’s disease using wearable sensors
-
Remote monitoring of physical activity in Veterans with Parkinson’s disease
-
Remote video-based research visits in a phase 3 clinical trial in Parkinson’s disease
-
Remotely-monitored home-based physiotherapy is feasible for both people with Parkinson’s disease and physiotherapists
-
Repetitive transcranial magnetic stimulation (rTMS) fails to improve cognition in patients with Parkinson’s disease: a meta-analysis of randomized controlled trials
-
Researches on the correlation between wearable device data and UPDRS scores in patients with Parkinson’s disease
-
Resistance Training on Postural Control in Parkinson’s Disease: a Randomized Controlled Trial
-
Resource patients involved in a program of therapeutic education of patients with Parkinson’s disease: contribution to patients’ recruitment
-
Respiratory training in Parkinson’s disease: a systematic review
-
Resting State Functional and Structural Connectivity Changes of Cerebellum Basal Ganglia Interconnecting Network in Parkinson’s Disease
-
Retinal Pathology in Parkinson’s Disease: A Longitudinal Study with Optical Coherence Tomography
-
Retinal thinning and disease worsening in Lewy body diseases
-
Retrospective review of MRI guided focused ultrasound thalamotomy referrals: experience from a single neuromodulation center
-
Rhythmic activity of subthalamic neurons during externally and internally generated movements in Parkinson’s disease
-
Rhythmic movements decompose in Parkinson’s disease with worse disease severity at low frequencies: akinesia or impaired ability to move more slowly than comfortable?
-
Right hemispheric β-amyloid deposition associates with freezing of gait in Parkinson’s disease
-
Risk Factors and Subtypes of Ischemic Stroke in Patients with Parkinson’s Disease
-
Risk of Hospital Admission in Patients with Parkinson’s disease Associated Psychosis (1991-2010)
-
Risk of Suicidal Ideation After Deep Brain Stimulation Surgery in Patients with Parkinson’s Disease
-
Robotic Assisted Arm Training in Parkinson’s disease rehabilitation: A pilot study
-
ROI based Machine Learning Classification Model for Spinocerebellar Ataxia type 12
-
Role of Sex in Parkinson’s Disease Progression
-
Rotenone exposure is associated with mitochondrial DNA (mtDNA) damage in humans
MDS Virtual Congress 2020
September 12-16, 2020. Virtual Congress. www.mdscongress.org